Certainly, the targeting of OLIG2 is feasible for gliomas in adults, but it should be noted that the degree of expression can vary in glioblastomas and astrocytoma while it is usually well expressed in oligodendrogliomas (325). The gene discussed is OLIG2; the disease is astrocytoma (excluding glioblastoma).